Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:psychotherapy
|
| gptkbp:administeredBy |
intravenous infusion
|
| gptkbp:alternativeName |
intravenous IgG
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:contains |
pooled immunoglobulin G
|
| gptkbp:contraindication |
IgA deficiency with anti-IgA antibodies
|
| gptkbp:derivedFrom |
human plasma
|
| https://www.w3.org/2000/01/rdf-schema#label |
IVIG
|
| gptkbp:mechanismOfAction |
modulates immune system
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
fever
headache allergic reaction renal dysfunction |
| gptkbp:standsFor |
intravenous immunoglobulin
|
| gptkbp:usedFor |
gptkb:chronic_inflammatory_demyelinating_polyneuropathy
gptkb:Guillain-Barré_syndrome gptkb:Kawasaki_disease autoimmune diseases immunodeficiency disorders immune thrombocytopenia |
| gptkbp:bfsParent |
gptkb:juvenile_dermatomyositis
gptkb:paraneoplastic_dermatomyositis |
| gptkbp:bfsLayer |
6
|